Thio-Linked UDP–Peptide Conjugates as O-GlcNAc Transferase Inhibitors

por Rafie, Karim, Gorelik, Andrii, Trapannone, Riccardo, Borodkin, Vladimir S., van Aalten, Daan M. F.
Publicado 2018

Direct Monitoring of Protein O-GlcNAcylation by High-Resolution Native Mass Spectrometry

por Leney, Aneika C., Rafie, Karim, van Aalten, Daan M. F., Heck, Albert J. R.
Publicado 2017

Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats

por Rafie, Karim, Raimi, Olawale, Ferenbach, Andrew T., Borodkin, Vladimir S., Kapuria, Vaibhav, van Aalten, Daan M. F.
Publicado 2017

Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation

por Kumar, Pravin, Schexnaydre, Erin, Rafie, Karim, Kurata, Tatsuaki, Terenin, Ilya, Hauryliuk, Vasili, Carlson, Lars‐Anders
Publicado 2022

Bisubstrate UDP–peptide conjugates as human O-GlcNAc transferase inhibitors

por Borodkin, Vladimir S., Schimpl, Marianne, Gundogdu, Mehmet, Rafie, Karim, Dorfmueller, Helge C., Robinson, David A., vanAalten, Daan M. F.
Publicado 2014

Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46

por Persson, B. David, John, Lijo, Rafie, Karim, Strebl, Michael, Frängsmyr, Lars, Ballmann, Monika Z., Mindler, Katja, Havenga, Menzo, Lemckert, Angelique, Stehle, Thilo, Carlson, Lars-Anders, Arnberg, Niklas
Publicado 2021